Anthropic Denied Data Access by Big Pharma

Anthropic's attempt to acquire proprietary data from major pharmaceutical companies for AI development was almost universally rejected. This highlights how pharmaceutical firms view data as a competitive moat, explaining the current limitations of AI in making major scientific discoveries.

2026-07-07 ~ 2026-07-07 · 2 related posts

• Anthropic Sought Data from Big Pharma, Faced Near-Unanimous Rejection — joecole · 2026-07-07
• Pharma Firms Reject Anthropic's Data Requests, Making Data the Moat for AI Drug Discovery — Hesamation · 2026-07-07